New! Sign up for our free email newsletter.
Science News
from research organizations

Drugs for treating severe hypertension in pregnancy compared

Date:
July 5, 2018
Source:
Wiley
Summary:
A recent meta-analysis of published studies has compared the efficacy and safety of antihypertensive drugs during pregnancy.
Share:
FULL STORY

A recent meta-analysis of published studies has compared the efficacy and safety of antihypertensive drugs during pregnancy.

In the British Journal of Clinical Pharmacology, investigators reported similar efficacy between nifedipine, hydralazine, and labetalol, and negligible differences were observed in their safety profile. The available evidence was inadequate for other drugs. Moderate quality of evidence was observed for direct comparison estimates between labetalol and hydralazine, but was either low or very low for other comparisons.

Labetalol, hydralazine, and nifedipine are likely comparable for treating acute-onset, severe hypertension in pregnancy, noted the authors, Dr. Kannan Sridharan and Prof. Reginald Sequeira, of Arabian Gulf University, in Bahrain.


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Kannan Sridharan, Reginald P. Sequeira. Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials. British Journal of Clinical Pharmacology, 2018; DOI: 10.1111/bcp.13649

Cite This Page:

Wiley. "Drugs for treating severe hypertension in pregnancy compared." ScienceDaily. ScienceDaily, 5 July 2018. <www.sciencedaily.com/releases/2018/07/180705114020.htm>.
Wiley. (2018, July 5). Drugs for treating severe hypertension in pregnancy compared. ScienceDaily. Retrieved December 27, 2024 from www.sciencedaily.com/releases/2018/07/180705114020.htm
Wiley. "Drugs for treating severe hypertension in pregnancy compared." ScienceDaily. www.sciencedaily.com/releases/2018/07/180705114020.htm (accessed December 27, 2024).

Explore More

from ScienceDaily

RELATED STORIES